Glossary

Another term for blinding in clinical trials.

The data collected at specific points during or at the end of the trial to assess outcomes.

Data collected at the start of a trial before the intervention begins.

A clinical trial conducted at multiple locations to enroll a larger or more diverse population.

A study design where participants are randomly assigned to treatment or control groups.

A clinical trial design in which participants and/or researchers do not know which treatment is being administered.

The main outcome measured to determine the effectiveness of a treatment.

Conditions under which a clinical trial would be stopped prematurely.

The physical location where participants receive treatments and data is collected.

The range of doses tested in a trial to evaluate safety and effectiveness.

An independent group overseeing participant safety and data integrity in a trial.

Efforts to ensure that clinical trial methods, data, and results are accessible and clearly reported.

The science of monitoring and assessing the safety of drugs, especially after they are approved.

Ongoing review of adverse events to identify patterns or safety concerns.